* Special issue dedicated to Dr. Guido Tettamanti.
1
Experimental Immunology, University Hospital, Hebelstrasse, 20
CH-4031 Basel, Switzerland.
2
Address reprint requests to: Tel: 41 61 265 2327; Fax: 41 61 265
2350; E-mail: Gennaro.DeLibero@unibas.ch
A New Aspect in Glycolipid Biology: Glycosphingolipids
as Antigens Recognized by T Lymphocytes*
G. De Libero,
1,2
A. Donda,
1
H.-J. Gober,
1
V. Manolova,
1
Z. Mazorra,
1
A. Shamshiev,
1
and L. Mori
1
(Accepted March 25, 2002)
T cells may recognize a large variety of ligands with different chemical structures. Recently,
glycosphingolipids have also been shown to stimulate human T lymphocytes. Recognition of
glycosphingolipids is restricted by the nonpolymorphic CD1 molecules, expressed by profes-
sional antigen-presenting cells and by macrophages infiltrating inflammatory sites. CD1 mole-
cules have a structure resembling that of classical MHC class I molecules, with the terminal
extracellular domains characterized by two antiparallel helices placed on two hydrophobic
pockets. The glycosphingolipids bound to CD1 insert the lipid tails in the two pockets and po-
sition the hydrophilic head on the external part of CD1. The TCR interacts with aminoacids
present in the two helices and with residues provided by the carbohydrate moiety of glyco-
sphingolipids and discriminates their structural variations. T cells recognizing self-glycosphin-
golipids release proinflammatory cytokines and may have a pathogenetic role in autoimmune
diseases such as multiple sclerosis.
KEY WORDS: Glycosphingolipids; T cells; CD1; TCR; autoimmunity; multiple sclerosis.
Neurochemical Research, Vol. 27, Nos. 7/8, August 2002 (© 2002), pp. 675–685
675
0364-3190/02/0800 –0675/0 © 2002 Plenum Publishing Corporation
origin. Loading of peptides on MHC molecules is a
highly regulated process involving several chaperones
and occurs in different intracellular organelles. MHC
class I molecules load peptides in the endoplasmic
reticulum, while MHC class II proteins in a specialized
late endosomal multivesicular body compartment.
T cells expressing the TCR recognize small
phosphorylated nonpeptidic metabolites (2). Recogni-
tion of these nonconventional ligands is very different
from recognition of protein antigens as it does not re-
quire presentation by classic MHC molecules and is
independent of antigen processing. Human T cells ex-
pressing the TCR composed of the V9 and V2
chains represent about 5–10% of circulating T cells,
cross-react with a variety of phosphorylated ligands,
and are readily activated. They are responsible for an
efficient sentinel system, which on detection of bacte-
rial infection immediately releases proinflammatory
cytokines (3).
INTRODUCTION
T lymphocytes recognize antigens using a surface
T cell receptor (TCR), which is composed of two dif-
ferent chains. Two types of TCR exist, which are made
by the association of the TCR and chains or the
and chains.
T cells expressing the TCR recognize small
peptides as antigens presented by MHC class I and II
proteins (1). Peptides are generated after fragmenta-
tion of proteins internalized in the antigen-presenting
cells by phagocytosis or receptor-mediated internal-
ization. Antigenic peptides may also derive from endo-
genously synthesized proteins such as proteins of viral